PREVENT AMPUTATIONS

In human trials of over 22 documented patients, our platform technology has shown clinical effectiveness in growing layers of tissue, resolving a range of slow or non-healing open wounds. This includes diabetic leg ulcers and burn wounds, which have previously been non-responsive to standard clinical therapy and diagnosed for amputations.

Our platform technology consists of a combination two part system. Gen-ray® accelerates tissue growth via our proprietary advanced photonics technology and  Hemastyl R® rapidly grows muscle, connective, vascular, dermal and epidermal tissues via our proprietary  wound healing substrate, eliminating grafts.